Barclays Downgrades Biomea Fusion to Equal-Weight, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Peter Lawson has downgraded Biomea Fusion (NASDAQ:BMEA) from Overweight to Equal-Weight and significantly lowered the price target from $30 to $5.
June 07, 2024 | 1:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays analyst Peter Lawson downgraded Biomea Fusion from Overweight to Equal-Weight and reduced the price target from $30 to $5.
The downgrade from Overweight to Equal-Weight and the significant reduction in the price target from $30 to $5 by Barclays is likely to negatively impact investor sentiment and the stock price of Biomea Fusion in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100